Indaptus Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
New York, NY
SEC filing record 1 source field available
Fiscal year end
31 December
Indaptus Therapeutics, Inc. has filed 316 SEC EDGAR filings since 20 Apr 2021

SEC filing history

Showing 76-100 of 316 matching filings.

Per page
25
Current page
4
ARS File 001-40652

ARS filing

Filing date
28 Apr 2025
Reporting date
31 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-40652

DEFA14A filing

Filing date
28 Apr 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-40652

DEF 14A

Filing date
28 Apr 2025
Reporting date
28 Apr 2025
Next action
Verify source filing
PRE 14A File 001-40652

PRE 14A filing

Filing date
17 Apr 2025
Reporting date
31 Dec 2024
Next action
Verify source filing
4

4 filing

Filing date
11 Apr 2025
Reporting date
10 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
11 Apr 2025
Reporting date
10 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
11 Apr 2025
Reporting date
10 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
11 Apr 2025
Reporting date
10 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
11 Apr 2025
Reporting date
10 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
11 Apr 2025
Reporting date
10 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
11 Apr 2025
Reporting date
10 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
DRS File 377-07826

DRS filing

Filing date
27 Mar 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-284863

EFFECT filing

Filing date
13 Mar 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-284863

POS AM filing

Filing date
13 Mar 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 001-40652

10-K filing

Filing date
13 Mar 2025
Reporting date
31 Dec 2024
Next action
Verify source filing
SCHEDULE 13G File 005-92776

SCHEDULE 13G filing

Filing date
18 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-284863

EFFECT filing

Filing date
13 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
13 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD File 333-284863

UPLOAD filing

Filing date
12 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-284707

EFFECT filing

Filing date
11 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
11 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .